The individual Pityriasis Rubra Pilaris area and severity index (iPRPASI): validity, reliability, and responsiveness of a novel patient-reported severity tool-Reference-Cited by-同舟云学术

The individual Pityriasis Rubra Pilaris area and severity index (iPRPASI): validity, reliability, and responsiveness of a novel patient-reported severity tool

Published:2023-08-02 Issue:10 Volume:315 Page:2933-2935
ISSN:1432-069X
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Shao Connie,Velasco Rose,Greiling Teri M.

Funder

Janssen Scientific Affairs

Eli Lilly and Company,United States

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00403-023-02682-7.pdf

Reference5 articles.

1. Boudreaux BW, Pincelli TP, Bhullar PK, Patel MH, Brumfiel CM, Li X, Heckman MG, Pittelkow MR, Mangold AR, Sluzevich JC (2022) Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis. Br J Dermatol 187(5):650–658. https://doi.org/10.1111/bjd.21708

2. Chularojanamontri L, Griffiths CE, Chalmers RJ (2013) The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis. J Invest Dermatol 133(8):1956–62. https://doi.org/10.1038/jid.2013.138

3. Haynes D, Strunck JL, Topham CA, Ortega-Loayza AG, Kent G, Cassidy PB, Hu R, Choate K, Wang Z, Liu Y, Greiling TM (2020) Evaluation of Ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial. JAMA Dermatol 156(6):668–675. https://doi.org/10.1001/jamadermatol.2020.0932

4. Ji-Xu A, Lei DK, Worswick S, Maloney NJ, Kim MM, Cutler L (2022) Patient and disease characteristics associated with psychiatric symptoms and impaired quality of life in pityriasis rubra pilaris. Br J Dermatol 187(6):1024–1026. https://doi.org/10.1111/bjd.21792. (Epub 2022 Aug 18 PMID: 35895853)

5. Velasco RC, Cutler B, McCue W, Greiling TM (2023) The comprehensive impact of pityriasis rubra pilaris on physical symptoms, mental health, and activities of daily living: a mixed methods study. JEADV Clin Pract. https://doi.org/10.1002/jvc2.107

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss-of-function mutations in Keratin 32 gene disrupt skin immune homeostasis in pityriasis rubra pilaris;Nature Communications;2024-07-24

2. Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options;American Journal of Clinical Dermatology;2023-12-30